| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.94B | -11.4% |
| Cost of Revenue | $2.02B | -13.7% |
| R&D Expense | $406.0M | -18.3% |
| SG&A Expense | $2.76B | -16.9% |
| Operating Income | $696.3M | -10.7% |
| Pre-tax Income | $403.5M | -3.6% |
| Income Tax | $112.3M | +589.0% |
| Net Income | $231.4M | -42.4% |
| EPS (Basic) | $1.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $375.7M | -21.5% |
| Accounts Receivable | $1.38B | -1.7% |
| Inventory | $2.15B | -10.3% |
| Current Assets | $4.43B | -9.4% |
| Total Assets | $21.07B | -10.2% |
| Current Liabilities | $2.36B | -32.0% |
| Long-term Debt | $1.00B | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $187.9M | +9.2% |
| -43.0% |
| EPS (Diluted) | $1.10 | -42.4% |
| Total Liabilities |
| $9.04B |
| -16.2% |
| Stockholders' Equity | $12.02B | -5.1% |